[1] |
FARDELLA C,MOSSO S C,GÓMEZ-SÁNCHEZ C,et al. Primary hyperaldosteronism in essential hypertensives:prevalence,biochemical profile,and molecular biology[J]. J Clin Endocrinol Metab,2000,85(5):1863-1867.
|
[2] |
CALHOUN D A,NISHIZAKA M K,ZAMAN M A,et al.Hyperaldosteronism among black and white subjects with resistant hypertension[J]. Hypertension,2002,40(6):892-896.
|
[3] |
FUNDER J W,CAREY R M,FARDELLA C,et al.Case detection,diagnosis,and treatment of patients with primary aldosteronism:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2008,93(9):3266-3281.
|
[4] |
FUNDER J W,CAREY R M,MANTERO F,et al.The management of primary aldosteronism:case detection,diagnosis,and treatment:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2016,101(5):1889-1916.
|
[5] |
吴冰,俞芳,张勇,等. 血浆醛固酮/肾素浓度比值诊断原发性醛固酮增多症的价值[J]. 检验医学,2019,34(2):130-135.
|
[6] |
SANG X,JIANG Y,WANG W,et al.Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China[J]. J Hypertension,2013,31(7):1465-1471.
|
[7] |
ROSSI G P,BERNINI G,CALIUMI C,et al.A prospective study of the prevalence of primary aldosteronism in 1 125 hypertensive patients[J]. J Am Coll Cardiol,2006,48(11):2293-2300.
|
[8] |
UNGER N,LOPEZ SCHMIDT I,PITT C,et al.Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass[J]. Eur J Endocrinol,2004,150(4):517-523.
|
[9] |
赖凤华,曹筱佩,林慧美,等. 两种血浆肾素、醛固酮检测方法对原发性醛固酮增多症筛查效率的评价[J]. 中华高血压杂志,2015,23(2):150-153.
|
[10] |
冷敏,刘爱云,司家峰,等. 化学发光法检测鲁西健康人群肾素-血管紧张素-醛固酮系统参考范围及影响因素[J]. 国际检验医学杂志,2018,39(15):1910-1914.
|
[11] |
孟凡森,王浩. 血浆肾素浓度诊断原发性醛固酮增多症的临床应用[J]. 中国继续医学教育,2015,7(30):40-42.
|